Trials / Withdrawn
WithdrawnNCT02242071
Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis
The Effect of Autologous Bone Marrow Mononuclear Cell Transplantation on Motor Neuron Disease/Amyotrophic Lateral Sclerosis
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Neurogen Brain and Spine Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The effect of autologous bone marrow mononuclear cells on Motor Neuron Disease/Amyotrophic Lateral Sclerosis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Stem Cell | intrathecal autologous bone marrow mononuclear cell transplantation |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2015-03-01
- Completion
- 2016-09-01
- First posted
- 2014-09-16
- Last updated
- 2018-10-25
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02242071. Inclusion in this directory is not an endorsement.